International Stroke Conference 2025  /  Updates on Cerebral White Matter Disease in 2025: Mechanisms, Implications, Treatment  /  Clinical Implications of White Matter Disease for Stroke Prevention
Logo

American Heart Association

  5
  0

Final ID:

Clinical Implications of White Matter Disease for Stroke Prevention

  • Stretz, Christoph  ( Brown University , Providence , Rhode Island , United States )
    • Author Disclosures:
    Christoph Stretz: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):Massachusetts General Hospital/Boston Scientific:Past (completed)
Meeting Info:

International Stroke Conference 2025

2025

Los Angeles, CA

Session Info:

Updates on Cerebral White Matter Disease in 2025: Mechanisms, Implications, Treatment

Friday, 02/07/2025 , 09:15AM - 10:45AM

ISC Invited Symposium

More abstracts on this topic:
Prevention and Treatment of White Matter Disease

Gottesman Rebecca, Rost Natalia, Wardlaw Joanna

Imaging Markers of White Matter Disease and Definitions

Wardlaw Joanna, Bath Philip

More abstracts from these authors:
Increased Prevalence of Device-Detected AF in ESUS Compared to Non-ESUS Stroke

Chang Jason, Yaghi Shadi, Shu Liqi, Goldstein Eric, Khan Farhan, Kala Narendra, Stretz Christoph, Burton Tina, Perelstein Elizabeth, Furie Karen

Determining Eligible Thrombolysis Candidates for Isolated Dizziness

Wasserstrom Briana, Mallick Dania, Furie Karen, Stretz Christoph, Burton Tina, Perelstein Elizabeth, Khan Farhan, Yaghi Shadi

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.

   Rate this abstract  (Maximum characters: 500)